Research programme: anti-tumour necrosis factor inhibitor - PeptinovAlternative Names: Anti-TNF inhibitor - Peptinov; Anti-TNF small molecule inhibitor - Peptinov; Anti-tumour necrosis factor inhibitor - Peptinov
Latest Information Update: 25 Jul 2016
At a glance
- Originator Peptinov
- Class Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Septic shock
Most Recent Events
- 25 Jul 2016 Early research in Septic shock in France (PO)
- 25 Jul 2016 Early research in Septic shock in France (Intraperitoneal)